Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.44 |
| ▸ | CES1 | P23141 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 5/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.42 |
| ▸ | PPARG | P37231 | 7/20 | 0.42 |
| ▸ | PPARD | Q03181 | 7/20 | 0.42 |
| ▸ | PPARA | Q07869 | 7/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.42 |
| ▸ | TLR2 | O60603 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | FABP4 | P15090 | 2/20 | 0.42 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.42 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27153313 | 1.00 | CES2 (0.44) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL22590076 | 1.00 | CES2 (0.44) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL16013176 | 1.00 | CES2 (0.44) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL27143894 | 1.00 | CES2 (0.44) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL25220702 | 0.97 | CES2 (0.42) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL17363811 | 0.91 | CES2 (0.41) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL29216406 | 0.91 | CES2 (0.41) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL17363810 | 0.91 | CES2 (0.41) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL17363644 | 0.91 | CES2 (0.41) | CES2CES1TSHRALDH1A1LMNA | |
| SCHEMBL11053685 | 0.91 | CES2 (0.41) | CES2CES1TSHRALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114796005-A | Anti-wrinkle polypeptide compound, cosmetic containing anti-wrinkle polypeptide compound and preparation method of anti-wrinkle polypeptide compound | 湖州闪思新材料科技有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-113914132-A | High-solid-content efficient wet strength agent for paper | 杭州绿邦科技有限公司 | 2022-01-11 | — | — | CN | claimed |
| CN-113876668-A | Anti-saccharification plant-derived composition, preparation method thereof and application thereof in beauty products | 北京青颜博识健康管理有限公司 | 2022-01-04 | — | — | CN | claimed |
| CN-113876640-A | Anti-saccharification seaweed-derived composition, preparation method thereof and application thereof in beauty products | 北京青颜博识健康管理有限公司 | 2022-01-04 | — | — | CN | claimed |
| CN-113876669-A | Anti-saccharification traditional Chinese medicine composition, preparation method thereof and application thereof in beauty products | 北京青颜博识健康管理有限公司 | 2022-01-04 | — | — | CN | claimed |
| CN-113376385-A | Preparation method of early pregnancy test paper | 湖北美宝生物科技股份有限公司 | 2021-09-10 | — | — | CN | claimed |
| CN-113341130-A | Early pregnancy test paper | 湖北美宝生物科技股份有限公司 | 2021-09-03 | — | — | CN | claimed |
| CN-108515173-B | Preparation method of composite metal powder new material | 济宁矿业集团海纳科技机电股份有限公司 | 2021-05-25 | — | — | CN | claimed |
| CN-112545905-A | Water-emulsion two-in-one emulsion and preparation method thereof | 上海和生化妆品有限公司 | 2021-03-26 | — | — | CN | claimed |
| CN-108570207-B | Preparation method of high-strength automobile new material | 博兴融智科技创新发展有限公司 | 2020-12-15 | — | — | CN | claimed |
| CN-111603414-A | Makeup removing cream and preparation method thereof | 成都律恩泽雅科技有限公司 | 2020-09-01 | — | — | CN | claimed |
| CN-111494236-A | Facial cleanser, moisturizing lotion and facial mask added with ganoderma lucidum polysaccharide and preparation method thereof | 福州仁量生物制品有限公司 | 2020-08-07 | — | — | CN | claimed |
| CN-111041825-A | Preparation process of antibacterial polyester carpet | 绍兴博利豪家纺有限公司 | 2020-04-21 | — | — | CN | claimed |
| CN-110913566-A | High-thermal-conductivity metal-based double-sided aluminum-based copper-clad plate and preparation process thereof | 乾乐欣展新材料技术（上海）有限公司 | 2020-03-24 | — | — | CN | claimed |
| EP-0430633-A1 | Paste insecticidal compositions | The Clorox Company (US) | 1991-06-05 | — | — | EP | claimed |
| US-20240099955-A1 | SKINCARE COMPOSITIONS AND METHODS OF USE THEREOF | HTL BIOTECHNOLOGY INNOVATION INC. | 2024-03-28 | — | — | US | disclosed |
| EP-4288084-A1 | SKINCARE COMPOSITIONS AND METHODS OF USE THEREOF | Modern Meadow, Inc. (US) | 2023-12-13 | — | — | EP | disclosed |
| US-20070031483-A1 | Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin | CEVC GREGOR | 2007-02-08 | — | — | US | disclosed |
| US-20040105881-A1 | Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin | IDEA AG (DE) | 2004-06-03 | — | — | US | disclosed |
| US-20040071767-A1 | NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery | IDEA AG (DE) | 2004-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040071767-A1 | NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery | SLC43A1, TRPV2, TRPA1 | CES2 3960/4885CES1 1820/4885TSHR 4716/4885 |
| US-20070031483-A1 | Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin | CUTA, ABCG2, PIGS | CES2 935/4885CES1 2798/4885TSHR 3410/4885 |
| US-20040105881-A1 | Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin | CUTA, ABCG2, PIGS | CES2 935/4885CES1 2798/4885TSHR 3410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.